A Retrospective Study of Pneumococcal Pneumonia in Hospitalized Patients Aged ≥65 Years in Izumo, Japan: 2010 to 2014

被引:0
|
作者
Hamaguchi, Megumi [1 ,5 ]
Tsubata, Yukari [1 ]
Yoshihara, Ken [1 ]
Nakao, Mika [1 ]
Amano, Yoshihiro [1 ]
Nakashima, Kazuhisa [1 ]
Hotta, Takamasa [2 ]
Okimoto, Tamio [1 ]
Hamaguchi, Shunichi [3 ]
Sutani, Akihisa [4 ]
Isobe, Takeshi [1 ]
机构
[1] Shimane Univ, Dept Internal Med, Div Med Oncol & Resp Med, Izumo, Shimane, Japan
[2] Shimane Prefectural Cent Hosp, Dept Resp Med, Izumo, Shimane, Japan
[3] Shimane Univ, Dept Gen Med, Izumo, Shimane, Japan
[4] Sutani Resp Clin, Izumo, Shimane, Japan
[5] Shimane Univ, Dept Internal Med, Div Med Oncol & Resp Med, 89-1,Enyacho, Izumo, Shimane, Japan
关键词
Streptococcus pneumoniae; pneumococcal pneumonia; vaccine; PPSV23; PCV13; POLYSACCHARIDE VACCINE; ADULTS; MORTALITY; IMPACT;
D O I
10.2147/IJGM.S407732
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: In Japan, both a 23-valent pneumococcal polysaccharide vaccine (PPSV23) and a 13-valent pneumococcal conjugate vaccine (PCV13) are available. Although randomized controlled trials have examined the effects of pneumococcal vaccines, few epidemiological studies have investigated the onset of pneumococcal pneumonia in general practice. In Izumo, Shimane Prefecture, Japan, a public subsidy for PPSV23 inoculation began in November 2012.Patients and Methods: The subjects were pneumonia patients aged 65 and over who were admitted to a hospital in Izumo. This retrospective study analyzed the following data extracted from medical records: pneumococcal pneumonia prevalence, pneumonia severity, mortality rate, PPSV23 vaccination rate, and length of hospital stay. The 2 years before the start of the public subsidy were defined as the early phase, and the 2 years after the subsidy initiation were defined as the late phase. We compared the two phases in terms of PPSV23 vaccination rate, prevalence and severity of pneumococcal pneumonia, and mortality rate.Results: We investigated data from a total of 1188 and 1086 patients in the early and late phases, respectively. The prevalence of pneumococcal pneumonia was 21.0% and 21.3% in the early and late phases, respectively. The mortality rate from pneumococcal pneumonia was 10.4% and 5.4% in the early and late phases, respectively (p = 0.080), indicating a 50% reduction. The PPSV23 vaccination rate (p < 0.001) and the comorbidity rates of chronic respiratory disease (p = 0.022) and chronic renal disease (p < 0.001) were significantly different between the early and late phases. Conclusion: This study showed that the rate of in-hospital deaths due to pneumococcal pneumonia was halved after the PPSV23 vaccine was subsidized. The causal relationship between the pneumococcal vaccination rate and the mortality rate of pneumococcal disease was unclear. Further investigation is deemed necessary.
引用
收藏
页码:2125 / 2132
页数:8
相关论文
共 50 条
  • [21] CURB-65 and Long-Term Mortality of Community-Acquired Pneumonia: A Retrospective Study on Hospitalized Patients
    Carlos, Pedro
    Gomes, Ricardo
    Coelho, Joana
    Chaves, Catarina
    Tuna, Celia
    Louro, Marlene
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
  • [22] Pneumococcal infection among community-acquired pneumonia.: A retrospective study of 230 hospitalized children
    Odievre, M. -H.
    Sannia, E.
    de Broucker, F.
    Bonnet, E.
    Michota, A. -S.
    Laurent, C.
    Valdes, L.
    Weil-Olivier, C.
    ARCHIVES DE PEDIATRIE, 2007, 14 (11): : 1290 - 1297
  • [23] Association of Pneumococcal Conjugate Vaccine Use With Hospitalized Pneumonia in Medicare Beneficiaries 65 Years or Older With and Without Medical Conditions, 2014 to 2017 (vol 183, pg 1, 2023)
    Kobayashi, M.
    MW, Spiller
    Wu, X.
    JAMA INTERNAL MEDICINE, 2023, 183 (03) : 278 - 278
  • [24] Effects of corticosteroids in hospitalized patients with Legionella pneumonia: A retrospective cohort study
    Beaty, William
    Elnadoury, Ola
    Fridman, David
    Louie, Eddie
    Lubinsky, Anthony Steven
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (09) : 849 - 854
  • [25] Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against Invasive Disease and Hospital-Treated Pneumonia Among People Aged ≥65 Years: A Retrospective Case-Control Study
    Leventer-Roberts, Maya
    Feldman, Becca S.
    Brufman, Ilan
    Cohen-Stavi, Chandra J.
    Hoshen, Moshe
    Balicer, Ran D.
    CLINICAL INFECTIOUS DISEASES, 2015, 60 (10) : 1472 - 1480
  • [26] Surgical treatment for vestibular schwannoma in patients aged=65-years: A retrospective multi-centric study
    Tropeano, Maria Pia
    Bono, Beatrice Claudia
    Lasio, Giovanni Battista
    Rossini, Zefferino
    Fornari, Maurizio
    Morenghi, Emanuela
    Skrap, Miran
    Ius, Tamara
    Pessina, Federico
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2022, 43 (06)
  • [27] Endoscopic gallbladder stenting for acute cholecystitis: a retrospective study of 46 elderly patients aged 65 years or older
    Maekawa, Satoshi
    Nomura, Ryosuke
    Murase, Takayuki
    Ann, Yasuyoshi
    Oeholm, Masayuki
    Harada, Masaru
    BMC GASTROENTEROLOGY, 2013, 13
  • [28] Risk of pneumonia recurrence in patients previously hospitalized for pneumonia -: A retrospective study (1998-2000)
    Polic-Vizintin, M
    Leppée, M
    Stimac, D
    Vodopija, I
    Cindric, J
    COLLEGIUM ANTROPOLOGICUM, 2005, 29 (01) : 213 - 219
  • [29] Clinical presentation and mortality in hospitalized patients aged 80+years with COVID-19-A retrospective cohort study
    Karlsson, Linda Katharina
    Jakobsen, Lasse Hjort
    Hollensberg, Louise
    Ryg, Jesper
    Midttun, Mette
    Frederiksen, Henrik
    Glenthoj, Andreas
    Kodahl, Anette Raskov
    Secher-Johnsen, Joanna
    Nielsen, Lene Kongsgaard
    Bofill, Nuria Gonzalez
    Knudtzen, Fredrikke Christie
    Lund, Cecilia Margareta
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2021, 94